HuR promotes castration-resistant prostate cancer progression by altering ERK5 activation via posttranscriptional regulation of BCAT1

ABSTRACT: Castration-resistant prostate cancer (CRPC) is refractory to hormone treatment, and its progression mechanism is not fully uncovered. This study aims to clarify the role and mechanism of Human antigen R (HuR) as a therapeutic target for CRPC progression.

ORGANISM(S): Homo sapiens

PROVIDER: GSE254851 | GEO | 2024/02/05

REPOSITORIES: GEO